is saxenda a glp 1 drug The GLP-1 Effect: How Modern Weight-Loss Drugs Alter Digestive Health | Cranford, NJ News TAPinto Saxenda (Liraglutide) | Lifestyle Medical

L., Heelan, K

86,87,88 Liraglutide was first approved by the FDA in 2010 under the brand name Victoza for the treatment of T2DM

5 Mechanistically, exercise-induced interleukin-6 (IL-6) appears to stimulate GLP-1 secretion from intestinal L-cells and pancreatic -cells in experimental models, which may contribute to improved appetite regulation and insulin secretion during and after exercise

Kim SY, Lee HW, Jung DK, et al

In 2014, a systematic review and metaanalysis of 82 followup studies on the body mass index (BMI) and survival of women with breast cancer found that obesity was consistently associated with an increased risk of total mortality and breast cancer mortality (41% and 35% respectively) compared with normalweight women [15]